Ae Wealth Management LLC Editas Medicine, Inc. Transaction History

Ae Wealth Management LLC

  • $9.76 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020
SELL
$14.88 - $32.78 $403,977 - $889,944
-27,149 Closed
0 $0
Q4 2019

Jan 15, 2020
BUY
$19.49 - $32.63 $150,189 - $251,446
7,706 Added 39.63%
27,149 $804,000
Q3 2019

Nov 05, 2019
SELL
$22.49 - $26.81 $899 - $1,072
-40 Reduced 0.21%
19,443 $442,000
Q2 2019

Jul 22, 2019
BUY
$20.48 - $27.76 $399,011 - $540,848
19,483 New
19,483 $482,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $82.5M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email